20
Boehringer Ingelheim Pharma Gmbh & Co. Kg Ingelheim Am Rhein De, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Homatropine Methylbromide, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2001-175 - Rev 02
This Chemical Type CEP, issued on March 16, 2012, remains in force until January 26, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 720 associated with this CEP further emphasizes